Laurus Labs Q1FY27 Results: Revenue Up 15% to ₹2,035 Cr, Profit ₹362 Cr
Laurus Labs reported Q1FY27 results. Consolidated revenue increased by 15% to ₹2,035.49 crore. Profit after tax surged to ₹361.99 crore. Standalone revenue grew to ₹1,777.23 crore, with profit after tax at ₹289.96 crore. The results were approved on July 24, 2026.
The announcement pertains to the quarterly financial results, which are a key determinant of investor sentiment and stock valuation. The substantial year-on-year growth in revenue and profit is a material event for the company.
The company reported significant year-on-year growth in both revenue and profit for the quarter ended June 30, 2026, on both consolidated and standalone bases, indicating strong financial performance.
Laurus Labs Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on July 24, 2026.
For the quarter ended June 30, 2026, the consolidated revenue from operations stood at ₹2,035.49 crore, marking a significant increase from ₹1,580.00 crore in the corresponding quarter of the previous year. Total income rose to ₹2,035.49 crore from ₹1,580.00 crore year-on-year. The company reported a consolidated profit after tax of ₹361.99 crore for the quarter, compared to ₹161.08 crore in the same period last year. The Board meeting commenced at 02:00 p.m. IST and concluded at 02:42 p.m. IST on July 24, 2026.
On a standalone basis, revenue from operations for the quarter ended June 30, 2026, was ₹1,777.23 crore, an increase from ₹1,454.27 crore in the prior year's quarter. Standalone profit after tax for the quarter was ₹289.96 crore, up from ₹157.94 crore in the year-ago period.
The company also mentioned that during the quarter, 393,001 equity shares of ₹2 each were allotted consequent to the exercise of stock options by employees. The financial results are available on the company's website and the websites of BSE and NSE.
What to do with a filing like this
Laurus Labs Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laurus Labs Limited. Read the original for the full detail.